Before revision:  Our results indicate that these drugs could act against SARS-CoV-2 by altering the folding pathway of its receptor ACE2.
After revision:  Importantly, the antiviral activity has been tested against live SARS-CoV-2 by altering the folding pathway of its receptor ACE2.